Nifuroxazide(又名硝呋齐特,硝呋酚酰肼)是一种口服的硝基呋喃类抗生素,是特异性的STAT3抑制剂,具有细胞渗透性和口服活性,是一种有效的止泻药,可以抑制细胞内STAT1/3/5转录活性的激活(IC50值为3 µM),通过下调JAK激酶自身磷酸化阻碍STAT3组成型磷酸化,抑制STAT转录因子的信号转导,降低骨髓瘤细胞存活性,具有抗肿瘤活性。
参考文献
[1]. Nelson Erik A, et al. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. 2008, 112(13):5095-102.
[2]. Yongxia Zhu, et al. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. 2016, 6(1): S110-962.
冰袋运输。粉末直接保存于-25~-15℃,有效期2年。建议避光干燥保存,避免反复冻融。
[1] Liu FF, Ren HY, Liu F, Qi WX, Liang CP, Zhang BX, Rao XJ. Time-series RNA sequencing reveals that immulectin-1 (IML-1) is a potential target for biological control of fall armyworm, Spodoptera frugiperda. Int J Biol Macromol. 2025 May;308(Pt 2):142466. doi: 10.1016/j.ijbiomac.2025.142466. Epub 2025 Mar 24. PMID: 40139608. IF:7.7





